Literature DB >> 11278373

Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes. Regulation of cell cycling as a downstream molecule of thrombopoietin signaling.

M Tanaka1, K Kirito, Y Kashii, M Uchida, T Watanabe, H Endo, T Endoh, K Sawada, K Ozawa, N Komatsu.   

Abstract

FKHRL1, a member of the Forkhead transcription factor family, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt. This molecule is a mammalian homolog of DAF-16, which plays an important role in the longevity of Caenorhabditis elegans. In this study we found that Akt and FKHRL1 proteins were detectable in highly purified normal human megakaryocytes and that these molecules were actually phosphorylated by thrombopoietin (TPO). To clarify the functional role of FKHRL1 in TPO signaling, we established a tetracycline-inducible system in the human TPO-dependent leukemia cell line UT-7/TPO. Induced expression of active FKHRL1 led to cell cycle arrest at G0/G1 phase in this cell line. These results suggest that FKHRL1 plays an important role in the cell cycle of megakaryocytic cells as one of the downstream target molecules of phosphatidylinositol 3-kinase-Akt, presumably mediated through the activation or inactivation of cell cycle-associated gene(s).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278373     DOI: 10.1074/jbc.M007958200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Mechanisms controlling differential promoter-occupancy by the yeast forkhead proteins Fkh1p and Fkh2p: implications for regulating the cell cycle and differentiation.

Authors:  P C Hollenhorst; G Pietz; C A Fox
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

2.  Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.

Authors:  Mie Soda; Karl Willert; Kenneth Kaushansky; Amy E Geddis
Journal:  Cell Signal       Date:  2008-09-06       Impact factor: 4.315

3.  A network map of thrombopoietin signaling.

Authors:  Firdous A Bhat; Jayshree Advani; Aafaque Ahmad Khan; Sonali Mohan; Arnab Pal; Harsha Gowda; Prantar Chakrabarti; T S Keshava Prasad; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2018-07-24       Impact factor: 5.782

4.  Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.

Authors:  Hiroaki Daitoku; Mitsutoki Hatta; Hitomi Matsuzaki; Satoko Aratani; Takayuki Ohshima; Makoto Miyagishi; Toshihiro Nakajima; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

Review 5.  "Sly as a FOXO": new paths with Forkhead signaling in the brain.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang
Journal:  Curr Neurovasc Res       Date:  2007-11       Impact factor: 1.990

6.  Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression.

Authors:  M Sugita; A Kalota; A M Gewirtz; M Carroll
Journal:  Leukemia       Date:  2012-11-06       Impact factor: 11.528

7.  Activation of FKHRL1 plays an important role in protecting erythroid cells from erythropoietin deprivation-induced apoptosis in a human erythropoietin-dependent leukemia cell line, UT-7/EPO.

Authors:  Mie Uchida; Keita Kirito; Hitoshi Endo; Keiya Ozawa; Norio Komatsu
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

8.  Notch1 intracellular domain increases cytoplasmic EZH2 levels during early megakaryopoiesis.

Authors:  A Roy; N P Basak; S Banerjee
Journal:  Cell Death Dis       Date:  2012-08-23       Impact factor: 8.469

9.  Identification of AIM2 as a downstream target of JAK2V617F.

Authors:  Ei Leen Liew; Marito Araki; Yumi Hironaka; Seiichi Mori; Tuan Zea Tan; Soji Morishita; Yoko Edahiro; Akimichi Ohsaka; Norio Komatsu
Journal:  Exp Hematol Oncol       Date:  2016-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.